John Gregg

John Gregg

Company: BalinBac Therapeutics

Job title: CEO


Addressing Viral Induced Dysbiosis in the Pulmonary & GI Microbiomes of Production Species 11:00 am

• New drug delivery systems can address challenge posed by viral, bacterial, and protozoal pathogens in the pulmonary and gi systems • Burdens of disease from viral pathogens like those causing bovine and porcine respiratory disease and african swine fever virus have huge economic impacts on protein production industries that could be mitigated by veterinary…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.